tirzepatide court case today Claim Eligibility for Injured Consumers Lilly seeks to intervene in

Liver-expressed antimicrobial peptide 2 (LEAP-2), the endogenous noncompetitive allosteric antagonist of the growth hormone secretagogue receptor 1a (GHSR1a), was recently identified as a key endocrine factor regulating systemic energy metabolism

Side Effect Management Some people experience mild nausea or fatigue 24 to 48 hours after their injection

In addition, one episode of severe hypoglycemia requiring intravenous glucose was reported in a WEGOVY-treated patient versus none in placebo-treated patients

A deficiency in Vitamin B12 can lead to fatigue, weakness, and even neurological complications

Ma IT, Madura JA